Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Moleculin Biotech (MBRX) Acquisitions (2016)

Moleculin Biotech (MBRX) has 1 years of Acquisitions data on record, last reported at $99638.0 in Q3 2016.